TABLE OF CONTENTS
1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.3 OVERVIEW OF GLOBAL DIGITAL DIABETES MANAGEMENT MARKET 22
1.4 CURRENCY AND PRICING 23
1.5 LIMITATIONS 24
1.6 MARKETS COVERED 24
2 MARKET SEGMENTATION 26
2.1 MARKETS COVERED 26
2.2 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL SCOPE 27
2.3 YEAR CONSIDERED FOR THE STUDY 28
2.4 CURRENCY AND PRICING 28
2.5 DBMR TRIPOD DATA VALIDATION MODEL 29
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
2.7 DBMR MARKET POSITION GRID 33
2.8 THE CATEGORY VS TIME GRID 34
2.9 VENDOR SHARE ANALYSIS 35
2.10 MULTIVARIATE MODELING 35
2.11 TIMELINE CURVE 36
2.12 SECONDARY SOURCES 37
2.13 ASSUMPTIONS 37
3 MARKET OVERVIEW 38
3.1 DRIVERS 40
3.1.1 INCREASING PREVALENCE OF DIABETES 40
3.1.2 INCREASING OBESITY 41
3.1.3 RISING NUMBER OF GERIATRIC POPULATION 42
3.1.4 HIGH ACCEPTANCE OF SOFTWARE APPLICATIONS RELATED TO DIABETES 42
3.2 RESTRAINTS 43
3.2.1 RECALL OF DEVICES 43
3.2.2 HIGH COST OF DEVICES 43
3.2.3 RIGID REIMBURSEMENT POLICY 44
3.2.4 TIME CONSUMING PRODUCT APPROVAL 44
3.3 OPPORTUNITIES 45
3.3.1 TECHNOLOGICAL INNOVATION 45
3.3.2 COLLABORATION AND PARTNERSHIP 46
3.3.3 EMERGING COUNTRY 46
3.4 CHALLENGES 47
3.4.1 TECHNOLOGY COMPETTION 47
3.4.2 STRINGENT REGULATION 47
3.4.3 LACK OF AWARENESS 48
4 REGULATORY PROCEDURE 49
4.1 PROCEDURE 49
4.2 REGULATION IN EUROPE 49
4.3 REGULATION IN REST OF THE WORLD 50
4.3.1 JAPAN 50
4.3.2 CHINA 50
4.3.3 INDIA 50
5 EXECUTIVE SUMMARY 51
6 PREMIUM INSIGHTS 54
7 INDUSTRY INSIGHT 56
8 GLOBAL DIGITAL DIABETES MANAGEMNET MARKET, BY PRODUCT & SERVICES 57
8.1 OVERVIEW 58
8.2 DEVICES 59
8.2.1 CONTINUOUS GLUCOSE MONITORING SYSTEMS 60
8.2.2 SMART GLUCOSE METERS 60
8.2.3 SMART INSULIN PENS 60
8.2.4 SMART INSULIN PUMPS 61
8.3 DIGITAL DIABETES MANAGEMENT APPS 61
8.3.1 WEIGHT & DIET MANAGEMENT APPS 62
8.3.2 DIABETES & BLOOD GLUCOSE TRACKING APPS 62
8.4 DATA MANAGEMENT SOFTWARE AND PLATFORMS 62
8.5 SERVICES 63
9 GLOBAL DIGITAL DIABETES MANAGEMNET MARKET, BY TYPE 64
9.1 OVERVIEW 65
9.2 HANDHELD DEVICES 66
9.3 WEARABLE DEVICES 67
10 GLOBAL DIGITAL DIABETES MANAGEMNET MARKET, BY END USER 68
10.1 OVERVIEW 69
10.2 HOME CARE SETTINGS 70
10.3 DIABETES CLINICS 71
10.4 ACADEMIC & RESEARCH INSTITUTES 71
10.5 OTHERS 72
11 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY GEOGRAPHY 73
11.1 OVERVIEW 74
11.2 NORTH AMERICA 79
11.2.1 U.S. 84
11.2.2 CANADA 86
11.2.3 MEXICO 88
11.3 EUROPE 90
11.3.1 GERMANY 95
11.3.2 U.K. 97
11.3.3 ITALY 99
11.3.4 FRANCE 101
11.3.5 SPAIN 103
11.3.6 NETHERLANDS 105
11.3.7 SWITZERLAND 107
11.3.8 TURKEY 109
11.3.9 BELGIUM 111
11.3.10 RUSSIA 113
11.3.11 REST OF EUROPE 114
11.4 ASIA-PACIFIC 115
11.4.1 CHINA 120
11.4.2 JAPAN 122
11.4.3 INDIA 124
11.4.4 SOUTH KOREA 126
11.4.5 AUSTRALIA 128
11.4.6 MALAYSIA 130
11.4.7 SINGAPORE 132
11.4.8 THAILAND 134
11.4.9 PHILIPPINES 136
11.4.10 INDONESIA 138
11.4.11 REST OF ASIA-PACIFIC 139
11.5 SOUTH AMERICA 140
11.5.1 BRAZIL 145
11.5.2 REST OF SOUTH AMERICA 146
11.6 MIDDLE EAST & AFRICA 147
11.6.1 SOUTH AFRICA 152
11.6.2 REST OF MIDDLE EAST & AFRICA 153
?
12 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, COMPANY LANDSCAPE 154
12.1 COMPANY SHARE ANALYSIS: GLOBAL 154
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 155
12.3 COMPANY SHARE ANALYSIS: EUROPE 156
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 157
13 COMPANY PROFILES 158
13.1 F. HOFFMANN-LA ROCHE LTD 158
13.1.1 COMPANY SNAPSHOT 158
13.1.2 SWOT ANALYSIS 158
13.1.3 REVENUE ANALYSIS 160
13.1.4 COMPANY SHARE ANALYSIS 160
13.1.5 GEOGRAPHICAL PRESENCE 161
13.1.6 PRODUCT PORTFOLIO 162
13.1.7 RECENT DEVELOPMENTS 163
13.1.8 DATA BRIDGE MARKET RESEARCH ANALYSIS 164
13.2 MEDTRONIC 165
13.2.1 COMPANY SNAPSHOT 165
13.2.2 SWOT ANALYSIS 165
13.2.3 REVENUE ANALYSIS 167
13.2.4 COMPANY SHARE ANALYSIS 168
13.2.5 GEOGRAPHICAL PRESENCE 168
13.2.6 PRODUCT PORTFOLIO 169
13.2.7 RECENT DEVELOPMENTS 170
13.2.8 DATA BRIDGE MARKET RESEARCH ANALYSIS 170
13.3 NOVO NORDISK A/S 171
13.3.1 COMPANY SNAPSHOT 171
13.3.2 SWOT ANALYSIS 171
13.3.3 REVENUE ANALYSIS 173
13.3.4 COMPANY SHARE ANALYSIS 173
13.3.5 GEOGRAPHICAL PRESENCE 174
13.3.6 PRODUCT PORTFOLIO 174
13.3.7 RECENT DEVELOPMENTS 175
13.3.8 DATA BRIDGE MARKET RESEARCH ANALYSIS 176
13.4 ABBOTT 177
13.4.1 COMPANY SNAPSHOT 177
13.4.2 SWOT ANALYSIS 177
13.4.3 REVENUE ANALYSIS 179
13.4.4 COMPANY SHARE ANALYSIS 179
13.4.5 GEOGRAPHICAL PRESENCE 180
13.4.6 PRODUCT PORTFOLIO 180
13.4.7 RECENT DEVELOPMENTS 181
13.4.8 DATA BRIDGE MARKET RESEARCH ANALYSIS 181
13.5 DEXCOM, INC 182
13.5.1 COMPANY SNAPSHOT 182
13.5.2 SWOT ANALYSIS 182
13.5.3 REVENUE ANALYSIS 184
13.5.4 COMPANY SHARE ANALYSIS 184
13.5.5 GEOGRAPHICAL PRESENCE 185
13.5.6 PRODUCT PORTFOLIO 185
13.5.7 RECENT DEVELOPMENTS 186
13.5.8 DATA BRIDGE MARKET RESEARCH ANALYSIS 186
13.6 AGAMATRIX, INC 187
13.6.1 COMPANY SNAPSHOT 187
13.6.2 GEOGRAPHICAL PRESENCE 187
13.6.3 PRODUCT PORTFOLIO 188
13.6.4 RECENT DEVELOPMENTS 188
13.7 AZUMIO 189
13.7.1 COMPANY SNAPSHOT 189
13.7.2 GEOGRAPHICAL PRESENCE 189
13.7.3 PRODUCT PORTFOLIO 190
13.7.4 RECENT DEVELOPMENTS 190
13.8 B. BRAUN MELSUNGEN AG 191
13.8.1 COMPANY SNAPSHOT 191
13.8.2 REVENUE ANALYSIS 191
13.8.3 GEOGRAPHICAL PRESENCE 192
13.8.4 PRODUCT PORTFOLIO 192
13.8.5 RECENT DEVELOPMENTS 193
13.9 BD 194
13.9.1 COMPANY SNAPSHOT 194
13.9.2 REVENUE ANALYSIS 194
13.9.3 GEOGRAPHICAL PRESENCE 195
13.9.4 PRODUCT PORTFOLIO 195
13.9.5 RECENT DEVELOPMENTS 196
13.10 DARIO HEALTH 197
13.10.1 COMPANY SNAPSHOT 197
13.10.2 REVENUE ANALYSIS 197
13.10.3 GEOGRAPHICAL PRESENCE 198
13.10.4 PRODUCT PORTFOLIO 198
13.10.5 RECENT DEVELOPMENTS 199
13.11 DIABNEXT 200
13.11.1 COMPANY SNAPSHOT 200
13.11.2 GEOGRAPHICAL PRESENCE 200
13.11.3 PRODUCT PORTFOLIO 201
13.11.4 RECENT DEVELOPMENTS 201
13.12 GLOOKO, INC 202
13.12.1 COMPANY SNAPSHOT 202
13.12.2 PRODUCT PORTFOLIO 202
13.12.3 RECENT DEVELOPMENTS 203
13.13 GLUCOME 204
13.13.1 COMPANY SNAPSHOT 204
13.13.2 PRODUCT PORTFOLIO 204
13.13.3 RECENT DEVELOPMENTS 205
13.14 INSULET CORPORATION 206
13.14.1 COMPANY SNAPSHOT 206
13.14.2 REVENUE ANALYSIS 206
13.14.3 GEOGRAPHICAL PRESENCE 207
13.14.4 PRODUCT PORTFOLIO 207
13.14.5 RECENT DEVELOPMENTS 208
13.15 LIFESCAN, INC 209
13.15.1 COMPANY SNAPSHOT 209
13.15.2 GEOGRAPHICAL PRESENCE 209
13.15.3 PRODUCT PORTFOLIO 210
13.15.4 RECENT DEVELOPMENTS 210
13.16 PHC HOLDINGS CORPORATION 211
13.16.1 COMPANY SNAPSHOT 211
13.16.2 GEOGRAPHICAL PRESENCE 211
13.16.3 PRODUCT PORTFOLIO 212
13.16.4 RECENT DEVELOPMENTS 212
13.17 SANOFI 213
13.17.1 COMPANY SNAPSHOT 213
13.17.2 REVENUE ANALYSIS 213
13.17.3 GEOGRAPHICAL PRESENCE 214
13.17.4 PRODUCT PORTFOLIO 214
13.17.5 RECENT DEVELOPMENTS 215
13.18 SMART METER LLC 216
13.18.1 COMPANY SNAPSHOT 216
13.18.2 PRODUCT PORTFOLIO 216
13.18.3 RECENT DEVELOPMENTS 216
?
13.19 TANDEM DIABETES CARE 217
13.19.1 COMPANY SNAPSHOT 217
13.19.2 REVENUE ANALYSIS 217
13.19.3 GEOGRAPHICAL PRESENCE 218
13.19.4 PRODUCT PORTFOLIO 218
13.19.5 RECENT DEVELOPMENTS 219
13.20 VOLUNTIS 220
13.20.1 COMPANY SNAPSHOT 220
13.20.2 GEOGRAPHICAL PRESENCE 220
13.20.3 PRODUCT PORTFOLIO 221
13.20.4 RECENT DEVELOPMENTS 221
14 CONCLUSION 222
15 QUESTIONNAIRE 223
16 RELATED REPORTS 225
?